Gapping up
In reaction to strong earnings/guidance:
- KOS +5%, ANH +2.9%, BHC +2.8%, DK +2.2%
M&A news:
- APC +3% (Occidental Petroleum (OXY) submits revised proposal to acquire Anadarko for $76.00/share).
Other news:
- AXSM +17% (announces that the development status and plan for AXS-05 in the treatment of major depressive disorder and treatment resistant depression have been expedited following a Breakthrough Therapy meeting with the FDA)
- SBGI +13.5% (Sinclair Broadcast to acquire 21 Regional Sports Networks from Disney (DIS) at a valuation of $10.6 bln / purchase price of $9.6 bln)
- ESPR +11.1% (FDA has accepted both New Drug Applications for bempedoic acid and the bempedoic acid / ezetimibe combination tablet for filing and regulatory review)
- ADAP +8.8% (announced significant clinical progress with partial responses in 4 out of 5 synovial sarcoma patients treated with ~10 billion cells in the ADP-A2M4 pilot study, and tumor shrinkage seen in nearly all assessed synovial sarcoma patients)
- ZYNE +6.7% (receives FDA Fast Track Designation for Zygel or treatment of behavioral symptoms associated with Fragile X Syndrome)
- VYGR +0.9% (Voyager Therapeutics and Neurocrine Biosciences (NBIX) present Phase I results for VY-AADC)
- NBIX +0.8% (Voyager Therapeutics and Neurocrine Biosciences (NBIX) present Phase I results for VY-AADC)
- RHT +0.8% (DOJ concludes review of IBM's proposed acquisition of Red Hat without remedies or conditions and received a notice of early termination of the waiting period)
Analyst comments:
- IMGN +5.6% (upgraded to Buy at H.C. Wainwright; upgraded to Outperform from Market Perform at Cowen)